Vident Investment Advisory’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,925
| Closed | -$707K | – | 885 |
|
|
2020
Q1 | $707K | Sell |
1,925
-120
| -6% | -$44.1K | 0.05% | 489 |
|
|
2019
Q4 | $1.45M | Buy |
2,045
+239
| +13% | +$169K | 0.09% | 339 |
|
|
2019
Q3 | $1.16M | Sell |
1,806
-51
| -3% | -$32.7K | 0.1% | 155 |
|
|
2019
Q2 | $1.62M | Buy |
+1,857
| New | +$1.62M | 0.13% | 107 |
|
|
2018
Q4 | – | Sell |
-3,670
| Closed | -$1.76M | – | 915 |
|
|
2018
Q3 | $1.76M | Sell |
3,670
-245
| -6% | -$118K | 0.07% | 352 |
|
|
2018
Q2 | $1.77M | Buy |
3,915
+1,248
| +47% | +$566K | 0.07% | 335 |
|
|
2018
Q1 | $1.74M | Buy |
2,667
+713
| +36% | +$466K | 0.07% | 330 |
|
|
2017
Q4 | $1.21M | Buy |
1,954
+546
| +39% | +$339K | 0.05% | 351 |
|
|
2017
Q3 | $1.3M | Buy |
1,408
+43
| +3% | +$39.6K | 0.07% | 332 |
|
|
2017
Q2 | $1.27M | Buy |
1,365
+445
| +48% | +$415K | 0.11% | 296 |
|
|
2017
Q1 | $875K | Buy |
920
+153
| +20% | +$146K | 0.09% | 315 |
|
|
2016
Q4 | $615K | Buy |
767
+42
| +6% | +$33.7K | 0.07% | 327 |
|
|
2016
Q3 | $612K | Sell |
725
-23
| -3% | -$19.4K | 0.08% | 324 |
|
|
2016
Q2 | $616K | Sell |
748
-244
| -25% | -$201K | 0.09% | 354 |
|
|
2016
Q1 | $1.1K | Buy |
992
+475
| +92% | +$529 | 0.07% | 349 |
|
|
2015
Q4 | $645K | Buy |
+517
| New | +$645K | 0.08% | 350 |
|